Credit Suisse Group set a €80.00 ($94.12) price objective on Gerresheimer AG (ETR:GXI) in a research report released on Tuesday morning. The firm currently has a buy rating on the stock.

Several other research analysts also recently commented on the stock. Berenberg Bank set a €75.00 ($88.24) price target on shares of Gerresheimer AG and gave the company a buy rating in a report on Monday, September 4th. Independent Research GmbH set a €78.00 ($91.76) price target on shares of Gerresheimer AG and gave the company a neutral rating in a report on Wednesday, July 19th. DZ Bank AG reissued a buy rating on shares of Gerresheimer AG in a report on Monday, July 17th. J P Morgan Chase & Co set a €99.40 ($116.94) price target on shares of Gerresheimer AG and gave the company a buy rating in a report on Thursday, August 31st. Finally, Deutsche Bank AG set a €62.00 ($72.94) price target on shares of Gerresheimer AG and gave the company a neutral rating in a report on Tuesday, September 5th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and five have assigned a buy rating to the stock. The company presently has a consensus rating of Hold and a consensus target price of €72.94 ($85.81).

Gerresheimer AG (ETR GXI) opened at 66.482 on Tuesday. The firm’s 50-day moving average is €65.42 and its 200 day moving average is €70.49. Gerresheimer AG has a 12 month low of €59.97 and a 12 month high of €79.47. The firm has a market capitalization of €2.09 billion and a P/E ratio of 18.416.

TRADEMARK VIOLATION NOTICE: “Gerresheimer AG (GXI) Given a €80.00 Price Target by Credit Suisse Group Analysts” was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece on another site, it was illegally stolen and reposted in violation of international copyright and trademark law. The legal version of this piece can be viewed at https://www.thecerbatgem.com/2017/10/11/gerresheimer-ag-gxi-given-a-80-00-price-target-by-credit-suisse-group-analysts.html.

Gerresheimer AG Company Profile

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, such as inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Analyst Recommendations for Gerresheimer AG (ETR:GXI)

Receive News & Stock Ratings for Gerresheimer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer AG and related stocks with our FREE daily email newsletter.